NCT01430806

Brief Summary

Recurrent ICD shocks are a serious problem in pts with ICD. Treatment failure with other antiarrhythmics and ablation are common. Dronedarone is a new antiarrhythmic drug with ion channel properties similar to amiodarone. Several case reports have shown promising results with Dronedarone for this patient population.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2011

Longer than P75 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 7, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 8, 2011

Completed
23 days until next milestone

Study Start

First participant enrolled

October 1, 2011

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

September 8, 2011

Status Verified

September 1, 2011

Enrollment Period

3.2 years

First QC Date

September 7, 2011

Last Update Submit

September 7, 2011

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of ICD shocks due to VT in the 6 months period after starting Dronedarone

    1 year

Study Arms (1)

Dronedrone Arm

OTHER
Drug: Dronedarone armDrug: Dronedarone

Interventions

PO Dronedarone 400 mg BID

Dronedrone Arm

Dronedarone PO 400 MG BID

Dronedrone Arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Recurernt ICD shocks depite other antiarrhythmic drug therapy

You may not qualify if:

  • CHF NYHA IV OR DECMPENSATED III
  • PERMANENT AF
  • LIVER DYSFUNCION
  • CR CLEARANCE \<30

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Dronedarone

Intervention Hierarchy (Ancestors)

AmiodaroneBenzofuransHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic Compounds

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Electrophysiology Service,

Study Record Dates

First Submitted

September 7, 2011

First Posted

September 8, 2011

Study Start

October 1, 2011

Primary Completion

December 1, 2014

Study Completion

December 1, 2015

Last Updated

September 8, 2011

Record last verified: 2011-09